A phase I clinical trial to evaluate the tolerability and safety of an allogeneic iPSC-derived iNKT cell and α-GalCer-pulsed autologous DC combination therapy for patients with recurrent and advanced head and neck cancer: A study protocol.
- DOI
- 10.1371/journal.pone.0342387
- Published
- 2026
- Container
- PloS one
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1371/journal.pone.0342387,
title = {A phase I clinical trial to evaluate the tolerability and safety of an allogeneic iPSC-derived iNKT cell and α-GalCer-pulsed autologous DC combination therapy for patients with recurrent and advanced head and neck cancer: A study protocol.},
author = {Kurokawa T and Iinuma T and Ebisu H and Yanagidaira T and Inaba Y and Fujiwara T and Hattori Y and Fukazawa T and Aoki T and Koseki H and Hanaoka H and Hanazawa T and Motohashi S},
year = {2026},
journal = {PloS one},
doi = {10.1371/journal.pone.0342387},
url = {https://doi.org/10.1371/journal.pone.0342387}
}RIS
TY - JOUR TI - A phase I clinical trial to evaluate the tolerability and safety of an allogeneic iPSC-derived iNKT cell and α-GalCer-pulsed autologous DC combination therapy for patients with recurrent and advanced head and neck cancer: A study protocol. AU - Kurokawa T AU - Iinuma T AU - Ebisu H AU - Yanagidaira T AU - Inaba Y AU - Fujiwara T AU - Hattori Y AU - Fukazawa T AU - Aoki T AU - Koseki H AU - Hanaoka H AU - Hanazawa T AU - Motohashi S PY - 2026 JO - PloS one DO - 10.1371/journal.pone.0342387 UR - https://doi.org/10.1371/journal.pone.0342387 ER -
APA
T, K., T, I., H, E., T, Y., Y, I., T, F., Y, H., T, F., T, A., H, K., H, H., T, H., & S, M. (2026). A phase I clinical trial to evaluate the tolerability and safety of an allogeneic iPSC-derived iNKT cell and α-GalCer-pulsed autologous DC combination therapy for patients with recurrent and advanced head and neck cancer: A study protocol.. PloS one. https://doi.org/10.1371/journal.pone.0342387
Source records
- pubmed · retrieved 2026-09-26T01:54:10.527Z